SCHEMBL5607403

SCHEMBL5607403

CCCOC(=O)C(=Cc1ccc(O)cc1)CCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.49
ALDH1A1 P00352 3/20 0.49
TSHR P16473 2/20 0.49
CHRM1 P11229 1/20 0.49
SLC6A2 P23975 1/20 0.49
KDR P35968 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
HSD17B3 P37058 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ABCG2 Q9UNQ0 2/20 0.41
MIF P14174 3/20 0.40
APP P05067 1/20 0.40
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6062333 0.91 MIF (0.48) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5606823 0.91 ESR1 (0.51) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5606476 0.89 ESR1 (0.50) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5607239 0.89 CA12 (0.50) ESR1ALDH1A1CA12CA1CA2
SCHEMBL5607546 0.85 ESR1 (0.51) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5607349 0.84 CA12 (0.44) ESR1ALDH1A1CA12CA1CA2
SCHEMBL12869950 0.83 MEN1 (0.56) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5607402 0.81 ESR1 (0.51) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5607399 0.81 ESR1 (0.51) ESR1ALDH1A1TSHRCHRM1SLC6A2
SCHEMBL5606791 0.81 ESR1 (0.51) ESR1ALDH1A1TSHRCHRM1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR ESR1 2687/4885ALDH1A1 5/4885TSHR 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.